Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Feb;79(2):468–472. doi: 10.1172/JCI112835

Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin.

D Y Leung, J C Burns, J W Newburger, R S Geha
PMCID: PMC424104  PMID: 2433307

Abstract

The effect of intravenous gammaglobulin (IVGG) on the immunoregulatory abnormalities found during acute Kawasaki syndrome (KS) was studied in a randomized trial of IVGG plus aspirin (ASA) versus ASA alone. Before therapy, patients in each treatment group had increased numbers of circulating HLA-DR-bearing Leu 3+ helper T cells, a deficiency of Leu 2+ suppressor/cytotoxic T cells, and increased levels of spontaneous IgG and IgM synthesis by peripheral blood mononuclear cells. There were no significant differences (P greater than 0.1) between immunologic parameters measured on day 1 and day 4 in the ASA-treated group. In contrast, patients treated with ASA plus IVGG had by day 4 a highly significant decrease in HLA-Dr+ Leu 3+ helper T cells (P less than 0.001), an increase in Leu 2+ suppressor/cytotoxic T cells (P less than 0.01), and a decrease in spontaneous IgG (P less than 0.01) and IgM synthesis (P less than 0.001). These changes were associated with a reduction in the secretion of T cell-derived B cell helper factors (P less than 0.001). These findings indicate that treatment with IVGG suppresses the marked T and B cell activation found in patients with acute KS.

Full text

PDF
468

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Durandy A., Fischer A., Griscelli C. Dysfunctions of pokeweed mitogen-stimulated T and B lymphocyte responses induced by gammaglobulin therapy. J Clin Invest. 1981 Mar;67(3):867–877. doi: 10.1172/JCI110104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ennis F. A., Meager A. Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus. J Exp Med. 1981 Nov 1;154(5):1279–1289. doi: 10.1084/jem.154.5.1279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Epstein L. B., Gupta S. Human T-lymphocyte subset production of immune (gamma) interferon. J Clin Immunol. 1981 Jul;1(3):186–194. doi: 10.1007/BF00922762. [DOI] [PubMed] [Google Scholar]
  4. Fossard C., Thompson R. A. Mucocutaneous lymph-node syndrome (Kawasaki disease): probable soluble-complex disorder. Br Med J. 1977 Apr 2;1(6065):883–883. doi: 10.1136/bmj.1.6065.883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Furusho K., Kamiya T., Nakano H., Kiyosawa N., Shinomiya K., Hayashidera T., Tamura T., Hirose O., Manabe Y., Yokoyama T. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet. 1984 Nov 10;2(8411):1055–1058. doi: 10.1016/s0140-6736(84)91504-6. [DOI] [PubMed] [Google Scholar]
  6. Groenewegen G., Buurman W. A., van der Linden C. J. Lymphokine dependence of in vivo expression of MHC class II antigens by endothelium. Nature. 1985 Jul 25;316(6026):361–363. doi: 10.1038/316361a0. [DOI] [PubMed] [Google Scholar]
  7. Hamashima Y., Tasaka K., Hirose S. [Etiological studies of Kawasaki disease (muco-cutaneous lymph node syndrome) -infectious disease theory]. Nihon Rinsho. 1976 Feb 10;34(2):290–294. [PubMed] [Google Scholar]
  8. Hirose S., Hamashima Y. Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome. A skin biopsy study of 27 patients. Eur J Pediatr. 1978 Aug 17;129(1):17–27. doi: 10.1007/BF00441370. [DOI] [PubMed] [Google Scholar]
  9. Kato H., Koike S., Yamamoto M., Ito Y., Yano E. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr. 1975 Jun;86(6):892–898. doi: 10.1016/s0022-3476(75)80220-4. [DOI] [PubMed] [Google Scholar]
  10. Kato S., Kimura M., Tsuji K., Kusakawa S., Asai T., Juji T., Kawasaki T. HLA antigens in Kawasaki disease. Pediatrics. 1978 Feb;61(2):252–255. [PubMed] [Google Scholar]
  11. Krensky A. M., Berenberg W., Shanley K., Yunis E. J. HLA antigens in mucocutaneous lymph node syndrome in New England. Pediatrics. 1981 May;67(5):741–743. [PubMed] [Google Scholar]
  12. Landing B. H., Larson E. J. Are infantile periarteritis nodosa with coronary artery involvement and fatal mucocutaneous lymph node syndrome the same? Comparison of 20 patients from North America with patients from Hawaii and Japan. Pediatrics. 1977 May;59(5):651–662. [PubMed] [Google Scholar]
  13. Leung D. Y., Chu E. T., Wood N., Grady S., Meade R., Geha R. S. Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome. J Immunol. 1983 May;130(5):2002–2004. [PubMed] [Google Scholar]
  14. Leung D. Y., Collins T., Lapierre L. A., Geha R. S., Pober J. S. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest. 1986 May;77(5):1428–1435. doi: 10.1172/JCI112454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Leung D. Y., Saryan J. A., Frankel R., Lareau M., Geha R. S. Impairment of the autologous mixed lymphocyte reaction in atopic dermatitis. J Clin Invest. 1983 Oct;72(4):1482–1486. doi: 10.1172/JCI111104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Leung D. Y., Siegel R. L., Grady S., Krensky A., Meade R., Reinherz E. L., Geha R. S. Immunoregulatory abnormalities in mucocutaneous lymph node syndrome. Clin Immunol Immunopathol. 1982 Apr;23(1):100–112. doi: 10.1016/0090-1229(82)90075-7. [DOI] [PubMed] [Google Scholar]
  17. Luster A. D., Unkeless J. C., Ravetch J. V. Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature. 1985 Jun 20;315(6021):672–676. doi: 10.1038/315672a0. [DOI] [PubMed] [Google Scholar]
  18. Mason W. H., Jordan S. C., Sakai R., Takahashi M., Bernstein B. Circulating immune complexes in Kawasaki syndrome. Pediatr Infect Dis. 1985 Jan-Feb;4(1):48–51. doi: 10.1097/00006454-198501000-00012. [DOI] [PubMed] [Google Scholar]
  19. Newburger J. W., Takahashi M., Burns J. C., Beiser A. S., Chung K. J., Duffy C. E., Glode M. P., Mason W. H., Reddy V., Sanders S. P. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986 Aug 7;315(6):341–347. doi: 10.1056/NEJM198608073150601. [DOI] [PubMed] [Google Scholar]
  20. Pober J. S., Gimbrone M. A., Jr, Cotran R. S., Reiss C. S., Burakoff S. J., Fiers W., Ault K. A. Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon. J Exp Med. 1983 Apr 1;157(4):1339–1353. doi: 10.1084/jem.157.4.1339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Stohl W. Modulation of the immune response by immunoglobulin for intravenous use. I. Inhibition of pokeweed mitogen-induced B cell differentiation. Clin Exp Immunol. 1985 Oct;62(1):200–207. [PMC free article] [PubMed] [Google Scholar]
  22. Umetsu D. T., Leung D. Y., Siraganian R., Jabara H. H., Geha R. S. Differential requirements of B cells from normal and allergic subjects for the induction of IgE synthesis by an alloreactive T cell clone. J Exp Med. 1985 Jul 1;162(1):202–214. doi: 10.1084/jem.162.1.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Weil J., Epstein C. J., Epstein L. B., Sedmak J. J., Sabran J. L., Grossberg S. E. A unique set of polypeptides is induced by gamma interferon in addition to those induced in common with alpha and beta interferons. Nature. 1983 Feb 3;301(5899):437–439. doi: 10.1038/301437a0. [DOI] [PubMed] [Google Scholar]
  24. Yoshikawa J., Yanagihara K., Owaki T., Kato H., Takagi Y., Okumachi F., Fukaya T., Tomita Y., Baba K. Cross-sectional echocardiographic diagnosis of coronary artery aneurysms in patients with the mucocutaneous lymph node syndrome. Circulation. 1979 Jan;59(1):133–139. doi: 10.1161/01.cir.59.1.133. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES